Interazioni tra farmaci
Empagliflozin-linagliptin + Fosphenytoin
Gravità: Maggiore
Empagliflozin-linagliptin and Fosphenytoin: major interaction.
Ultimo aggiornamento
Per operatori sanitari — solo a scopo di riferimento. Questa pagina è una sintesi breve, non è un parere medico e non sostituisce il RCP ufficiale né il giudizio clinico. Verificare sempre prima di prescrivere o dispensare.
Il contenuto clinico di questa pagina è disponibile solo in inglese.
Sintesi
Fosphenytoin is converted to phenytoin, a strong inducer of CYP3A4 and P-glycoprotein, which can substantially lower linagliptin exposure. Loss of linagliptin effect may lead to worsened glycemic control.
Cosa significa questa interazione in parole semplici
Empagliflozin-linagliptin and Fosphenytoin can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
Empagliflozin-linagliptin belongs to Endocrine; Fosphenytoin belongs to Central Nervous System.
Perché avviene
Phenytoin induces CYP3A4 and P-glycoprotein, increasing linagliptin clearance.
Cosa fare
Linagliptin labeling advises an alternative to strong inducers; use a different antidiabetic agent where possible, otherwise monitor glucose and HbA1c closely.
Cosa chiedere al farmacista
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
Per gli utenti Pro+
Sblocca la pagina completa
Crei un account e avvii una prova di Pro+ per sbloccare le indicazioni complete sulla gestione di Empagliflozin-linagliptin e Fosphenytoin, le note aggiuntive, il dettaglio delle evidenze e il controllo delle interazioni per un'intera prescrizione.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Provi Pro+ gratis per 14 giorni sul web. Nessuna carta.
Altre interazioni di Empagliflozin-linagliptin
Altre interazioni di Fosphenytoin
- Dronedarone + Fosphenytoin Controindicata
- Fosphenytoin + Ledipasvir-sofosbuvir Controindicata
- Fosphenytoin + Lorlatinib Controindicata
- Fosphenytoin + Lurasidone Controindicata
- Fosphenytoin + Ranolazine Controindicata
- Fosphenytoin + Sofosbuvir-velpatasvir-voxilaprevir Controindicata
Domande frequenti
Can I take Empagliflozin-linagliptin with Fosphenytoin?
MediHelp rates the interaction as major. Empagliflozin-linagliptin and Fosphenytoin can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Fosphenytoin is converted to phenytoin, a strong inducer of CYP3A4 and P-glycoprotein, which can substantially lower linagliptin exposure. Loss of linagliptin effect may lead to worsened glycemic control.
How serious is the interaction between Empagliflozin-linagliptin and Fosphenytoin?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Linagliptin labeling advises an alternative to strong inducers; use a different antidiabetic agent where possible, otherwise monitor glucose and HbA1c closely.
What other medicines interact with Empagliflozin-linagliptin?
MediHelp also lists interactions of Empagliflozin-linagliptin with, for example, Rifampin, Rifapentine, Amiloride. The full list is on the Empagliflozin-linagliptin page.
Monografie complete, posologie e verifica delle interazioni nell'app MediHelp
Apra il riferimento completo, verifichi le interazioni tra più farmaci e usi gli strumenti di posologia nell'app MediHelp.
